Pfizer preparing to raise its bid for Metsera, WSJ reports
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
A Pfizer research facility is shown in the La Jolla neighborhood of San Diego, California, U.S., September 30, 2025. REUTERS/Mike Blake
(Reuters) -Pfizer is preparing to sweeten its offer again for Metsera, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Sriraj Kalluvila)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crypto dips on Democrat midterm wins, Binance hack dent optimism
- Novo Nordisk raises 2026 outlook as Wegovy pill beats forecasts
- Hakeem Jeffries poised to become speaker of US House of Representatives
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
